Regulatory Approvals: the DMF of UMECLIDINIUM BROMIDE has been submitted to FDA under GDUFA procedure

Olon officially announces that the DMF of UMECLIDINIUM BROMIDE has been submitted to FDA under GDUFA procedure.

Umeclidinium Bromide is a high potent API with indication for Chronic Obstructive Pulmonary Disease (COPD), Chronic Bronchitis, Emphysema.

Olon is the only manufacturer in the European Union.